Author
Listed:
- Kim YS
(T-stem Co., Ltd., Changwon, Gyeongsangnam-do, Republic of Korea)
- SE Ha
(Research Institute of Life Science and College of Veterinary Medicine, Gyeongsang National University, Jinju-daero, Jinju, Republic of Korea)
- H Bae
(College of Veterinary Medicine, Gyeongsang National University, Jinju-daero, Jinju, Republic of Korea)
- D Lee
(College of Veterinary Medicine, Gyeongsang National University, Jinju-daero, Jinju, Republic of Korea)
- DH Yu
(College of Veterinary Medicine, Gyeongsang National University, Jinju-daero, Jinju, Republic of Korea)
- GS Kim
(Research Institute of Life Science and College of Veterinary Medicine, Gyeongsang National University, Jinju-daero, Jinju, Republic of Korea)
Abstract
Despite various treatment options for canine atopic dermatitis (cAD), therapeutic limitations still exist, including adverse effects and low absorption ratios. This study evaluated the effects of a membrane-free stem cell extract (MFSCE) on the clinical signs of atopic dogs. Thirty client-owned dogs previously diagnosed with cAD were separated into placebo (n = 10) and MFSCE-treated groups (n = 20). The dogs were treated with a cream (MFSCE and placebo) via dermal administration twice daily for 14 days, and the clinical response was recorded on days 0, 7, and 14. The MFSCE-treated group showed significantly decreased severity of pruritus on day 14 compared to that on day 0. In addition, the erythema, pigmentation, skin dryness, and thickness were remarkably decreased in the MFSCE-treated group on day 14 compared to those on day 0 whereas no significant changes were observed in the placebo-treated group. No general clinical signs or adverse effects were observed in this study. These results suggest that MFSCE could be a surrogate treatment option for cAD.
Suggested Citation
Kim YS & SE Ha & H Bae & D Lee & DH Yu & GS Kim, 2022.
"Clinical efficacy of membrane-free stem cell extracts for the treatment of canine atopic dermatitis,"
Veterinární medicína, Czech Academy of Agricultural Sciences, vol. 67(9), pages 463-470.
Handle:
RePEc:caa:jnlvet:v:67:y:2022:i:9:id:136-2021-vetmed
DOI: 10.17221/136/2021-VETMED
Download full text from publisher
As the access to this document is restricted, you may want to
for a different version of it.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:caa:jnlvet:v:67:y:2022:i:9:id:136-2021-vetmed. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Ivo Andrle (email available below). General contact details of provider: https://www.cazv.cz/en/home/ .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.